Andrew Goldberg
Directeur/Bestuurslid bij TARSUS PHARMACEUTICALS, INC.
Vermogen: 209 296 $ op 31-05-2024
Profiel
Andrew D.
Goldberg is an Independent Director at Tarsus Pharmaceuticals, Inc. He previously served as Chairman at Swift Health Systems, Inc., Director at Ossium Health, Inc., and Vice President & Market Strategist at JPMorgan Investment Management, Inc. from 2002 to 2011.
He received his undergraduate degree from Bryant University and his doctorate from George Washington University School of Medicine & Health.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 24-06-2024 | 6 350 ( 0.02% ) | 209 296 $ | 31-05-2024 |
Actieve functies van Andrew Goldberg
| Bedrijven | Functie | Begin |
|---|---|---|
| TARSUS PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 01-08-2020 |
Eerdere bekende functies van Andrew Goldberg
| Bedrijven | Functie | Einde |
|---|---|---|
Swift Health Systems, Inc.
 Swift Health Systems, Inc. Medical SpecialtiesHealth Technology Swift Health Systems, Inc. provides healthcare services. It offers dental solutions. The company was founded by John Pham and Hongsheng Tong in 2014 and is headquartered in Irvine, CA. | Voorzitter | - |
Ossium Health, Inc.
 Ossium Health, Inc. Miscellaneous Commercial ServicesCommercial Services Ossium Health, Inc. provides biotechnology services. It offers bone marrow banking, cryopreservation, stem cell biology, therapy and cell transplant. The company was founded by Sebastian Eriksson Giwa, Kevin Caldwell and Erik Woods in 2016 and is headquartered in San Francisco, CA. | Directeur/Bestuurslid | - |
JPMorgan Investment Management, Inc.
 JPMorgan Investment Management, Inc. Investment ManagersFinance JPMorgan Investment Management, Inc. (JPMIM) is a global, SEC-registered investment advisor headquartered in New York City. The firm was founded in 2000 as the result of Chase Manhattan's purchase of Robert Fleming Holdings and the subsequent merger of Chase and JPMorgan. In January 2010, JPMorgan Investment Advisors merged into JP Morgan Investment Management. JPMIM is a subsidiary of JPMorgan Asset Management Holdings, Inc., ultimately owned by JPMorgan Chase & Co. (NYSE: JPM). The firm primarily provides investment advisory services to both US and non-US institutional and retail clients. | Marktstrateeg | - |
Opleiding van Andrew Goldberg
| Bryant University | Undergraduate Degree |
| George Washington University School of Medicine & Health | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| TARSUS PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
JPMorgan Investment Management, Inc.
JPMorgan Investment Management, Inc. Investment ManagersFinance JPMorgan Investment Management, Inc. (JPMIM) is a global, SEC-registered investment advisor headquartered in New York City. The firm was founded in 2000 as the result of Chase Manhattan's purchase of Robert Fleming Holdings and the subsequent merger of Chase and JPMorgan. In January 2010, JPMorgan Investment Advisors merged into JP Morgan Investment Management. JPMIM is a subsidiary of JPMorgan Asset Management Holdings, Inc., ultimately owned by JPMorgan Chase & Co. (NYSE: JPM). The firm primarily provides investment advisory services to both US and non-US institutional and retail clients. | Finance |
Swift Health Systems, Inc.
Swift Health Systems, Inc. Medical SpecialtiesHealth Technology Swift Health Systems, Inc. provides healthcare services. It offers dental solutions. The company was founded by John Pham and Hongsheng Tong in 2014 and is headquartered in Irvine, CA. | Health Technology |
Ossium Health, Inc.
Ossium Health, Inc. Miscellaneous Commercial ServicesCommercial Services Ossium Health, Inc. provides biotechnology services. It offers bone marrow banking, cryopreservation, stem cell biology, therapy and cell transplant. The company was founded by Sebastian Eriksson Giwa, Kevin Caldwell and Erik Woods in 2016 and is headquartered in San Francisco, CA. | Commercial Services |
